Corindus Vascular Robotics (CVRS) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Corindus Vascular Robotics (CVRS) PT Raised to $2 at Ladenburg Thalmann
March 13, 2019 9:18 AM EDTLadenburg Thalmann analyst Jeffrey Cohen raised the price target on Corindus Vascular Robotics (NYSE: CVRS) to $2.00 (from $1.70) while maintaining a Buy rating following the company's 4Q. Revenue, net loss, and loss per share for the quarter was $4.7 million, $7.4 million, and $0.04. Consensus estimate for the quarter were... More



